150 related articles for article (PubMed ID: 4089831)
21. Effect of pyridoxal 5'-phosphate (PALP) on human platelet aggregation, dense granule release and thromboxane B2 generation--role of Schiff base formation.
Krishnamurthi S; Westwick J; Kakkar VV
Thromb Haemost; 1982 Oct; 48(2):136-41. PubMed ID: 6891107
[TBL] [Abstract][Full Text] [Related]
22. Removal of extraplatelet Na+ eliminates indomethacin-sensitive secretion from human platelets stimulated by epinephrine, ADP, and thrombin.
Connolly TM; Limbird LE
Proc Natl Acad Sci U S A; 1983 Sep; 80(17):5320-4. PubMed ID: 6577431
[TBL] [Abstract][Full Text] [Related]
23. The effect of halofenate--free acid on aggregation--the release reaction, coagulant activity, and lipid metabolism of human platelets.
Huzoor-Akbar ; Ardlie NG
Thromb Haemost; 1977 Oct; 38(3):612-9. PubMed ID: 579507
[TBL] [Abstract][Full Text] [Related]
24. Effects of vinblastine on malondialdehyde formation, serotonin release and aggregation in human platelets.
Brammer JP; Kerecsen L; Maguire MH
Eur J Pharmacol; 1982 Jul; 81(4):577-85. PubMed ID: 6811295
[TBL] [Abstract][Full Text] [Related]
25. Modification of platelet functions by monobromobimane, a fluorescent thiol group label.
Zucker MB; Mauss EA
Thromb Haemost; 1986 Apr; 55(2):228-34. PubMed ID: 3012818
[TBL] [Abstract][Full Text] [Related]
26. In-vitro and ex-vivo inhibition of blood platelet aggregation by naftazone.
Durand P; Bloy C; Peltier-Pujol F; Blache D
J Pharm Pharmacol; 1996 Jun; 48(6):566-72. PubMed ID: 8832488
[TBL] [Abstract][Full Text] [Related]
27. Weak inhibition of protein kinase C coupled with various non-specific effects make sphingosine an unsuitable tool in platelet signal transduction studies.
Krishnamurthi S; Patel Y; Kakkar VV
Biochim Biophys Acta; 1989 Feb; 1010(2):258-64. PubMed ID: 2492201
[TBL] [Abstract][Full Text] [Related]
28. PPACK-thrombin inhibits thrombin-induced platelet aggregation and cytoplasmic acidification but does not inhibit platelet shape change.
Greco NJ; Tenner TE; Tandon NN; Jamieson GA
Blood; 1990 May; 75(10):1989-90. PubMed ID: 2337670
[TBL] [Abstract][Full Text] [Related]
29. Plasmin inhibition of thrombin-induced platelet aggregation.
Miller JL; Katz AJ; Feinstein MB
Thromb Diath Haemorrh; 1975 Apr; 33(2):286-309. PubMed ID: 124475
[TBL] [Abstract][Full Text] [Related]
30. Interaction of local anaesthetics with blood platelet aggregation.
Jancinová V; Nosál' R; Benes L
Drugs Exp Clin Res; 1986; 12(9-10):857-60. PubMed ID: 3792211
[TBL] [Abstract][Full Text] [Related]
31. Effects on platelet function of removal of platelet sialic acid by neuraminidase.
Greenberg J; Packham MA; Cazenave JP; Reimers HJ; Mustard JF
Lab Invest; 1975 Apr; 32(4):476-84. PubMed ID: 1127870
[TBL] [Abstract][Full Text] [Related]
32. Activation of phospholipase C and protein kinase C has little involvement in ADP-induced primary aggregation of human platelets: effects of diacylglycerols, the diacylglycerols, the diacylglycerol kinase inhibitor R59022, staurosporine and okadaic acid.
Packham MA; Livne AA; Ruben DH; Rand ML
Biochem J; 1993 Mar; 290 ( Pt 3)(Pt 3):849-56. PubMed ID: 8384448
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of human platelet function by sulfatides.
Devaiah AK; Raife TJ; Barton JA; Olson JD
Blood Coagul Fibrinolysis; 2000 Sep; 11(6):543-50. PubMed ID: 10997794
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of [3H]platelet activating factor (PAF) binding by Zn2+: a possible explanation for its specific PAF antiaggregating effects in human platelets.
Nunez D; Kumar R; Hanahan DJ
Arch Biochem Biophys; 1989 Aug; 272(2):466-75. PubMed ID: 2502069
[TBL] [Abstract][Full Text] [Related]
35. Storage of platelets for tests of platelet function: effects of pH on platelet aggregation and liberation of beta-thromboglobulin.
Watts SE; Tunbridge LJ; Lloyd JV
Thromb Res; 1983 Feb; 29(3):343-53. PubMed ID: 6221437
[TBL] [Abstract][Full Text] [Related]
36. Pretreatment of human platelets with plasmin inhibits responses to thrombin, but potentiates responses to low concentrations of aggregating agents, including the thrombin receptor activating peptide, SFLLRN.
Kinlough-Rathbone RL; Perry DW; Rand ML; Packham MA
Thromb Haemost; 1997 Apr; 77(4):741-7. PubMed ID: 9134653
[TBL] [Abstract][Full Text] [Related]
37. Effects of nicotine on platelet function.
Pfueller SL; Burns P; Mak K; Firkin BG
Haemostasis; 1988; 18(3):163-9. PubMed ID: 3181816
[TBL] [Abstract][Full Text] [Related]
38. Properties of washed human platelets.
Kinlough-Rathbone RL; Mustard JF; Packham MA; Perry DW; Reimers HJ; Cazenave JP
Thromb Haemost; 1977 Apr; 37(2):291-308. PubMed ID: 327607
[TBL] [Abstract][Full Text] [Related]
39. Differential effects of cytochalasin B on platelet release, aggregation and contractility: evidence against a contractile mechanism for the release of platelet granular contents.
Kirkpatrick JP; McIntire LV; Moake JL; Cimo PL
Thromb Haemost; 1980 Feb; 42(5):1483-9. PubMed ID: 6892735
[TBL] [Abstract][Full Text] [Related]
40. Diurnal variation in melatonin effect on adenosine triphosphate and serotonin release by human platelets.
Del Zar MM; Martinuzzo M; Cardinali DP; Carreras LO; Vacas MI
Acta Endocrinol (Copenh); 1990 Oct; 123(4):453-8. PubMed ID: 2239090
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
